Cimatron (CIMT) Reports Strong Third Quarter Results with Net Profit of $0.9M on a Non-GAAP Basis
GIVAT SHMUEL, Israel, November 10, 2010 /PRNewswire-FirstCall/ — Cimatron Limited (NASDAQ: CIMT) (“Cimatron” or the “Company”), a leading provider of integrated CAD/CAM solutions for the toolmaking and manufacturing industries, today announced financial results for the third quarter and first nine months of 2010.
Financial highlights
- Q3/10 total revenue up 26% year-over-year on a constant currency basis
- Q3/10 new licenses revenue up 51% year-over-year on a constant currency
basis
- Operating results in the first nine months of 2010 improved by $2.5M
year-over-year
- $4.3 million positive cash flow from operating activities in the first
nine months of 2010, an 86% year-over-year increase
- $10.2M cash balance at end of Q3/10
Commenting on the results, Danny Haran, President and Chief Executive Officer of Cimatron, said “We are very pleased with the strong third quarter results. We have seen solid growth in all our territories and all product lines, in what seems more and more like a sustainable market recovery. Traditionally, the third quarter is the weakest quarter of each year, due to the long summer vacations. This year presents a notable exception, with quarter-over-quarter improvement in all parameters from the second to the third quarter. The combination of continued revenue growth and tight budget control results in significant profitability improvement and strong cash flow. We are especially excited about the rapid growth in sales of new licenses, which is the best indication of market confidence and change in the business environment. Early indications suggest that this trend continues into Q4, which is traditionally the strongest quarter of each year”, concluded Mr. Haran.
The following provides details on Cimatron’s GAAP and non-GAAP results for the third quarter and first nine months of 2010:
GAAP:
Revenues for the third quarter of 2010 were $8.7 million, compared to $7.2 million recorded in the third quarter of 2009. For the first nine months of 2010, revenues were $25.1 million, compared to $23.2 million in the same period of 2009.
Gross Profit for the third quarter of 2010 was $7.3 million as compared to $5.8 million in the same period in 2009. Gross margin in the third quarter of 2010 was 84% of revenues, compared to a gross margin of 80% in the same quarter of 2009. For the first nine months of 2010, gross profit was $20.8 million, compared to $18.7 million in the same period of 2009. Gross margin for the nine months ended on September 30th, 2010 was 83% compared to a gross margin of 81% in the first nine months of 2009.
Operating profit in the third quarter of 2010 was $479 thousand, compared to an operating loss of $(901) thousand in the third quarter of 2009. In the first nine months of 2010, Cimatron recorded an operating profit of $726 thousand, compared to an operating loss of $(1.73) million in the first nine months of 2009.
Net Profit for the third quarter of 2010 was $320 thousand, or $0.04 per diluted share, compared to a net loss of $(731) thousand, or $(0.08) per diluted share recorded in the same quarter of 2009. In the first nine months of 2010 net profit was $498 thousand, or $0.06 per diluted share, compared to a net loss of $(1.38) million, or $(0.15) per diluted share, in the first nine months of 2009.
Non-GAAP:
Revenues for the third quarter of 2010 were $8.7 million, compared to $7.2 million recorded in the third quarter of 2009. For the first nine months of 2010, revenues were $25.1 million, compared to $23.2 million in the same period of 2009.
Gross Profit for the third quarter of 2010 was $7.5 million as compared to $6.0 million in the same period in 2009. Gross margin in the third quarter of 2010 was 85% of revenues, compared to a gross margin of 82% in the same quarter of 2009. In the first nine months of 2010, gross profit was $21.3 million, compared to $19.2 million in the first nine months of 2009. Gross margin for the nine months ended on September 30th, 2010 was 85%, compared to 83% in the first nine months of 2009.
Operating Profit in the third quarter of 2010 was $725 thousand, compared to an operating loss of $(654) thousand in the third quarter of 2009. In the first nine months of 2010, Cimatron reports an operating profit of $1.46 million, compared to operating loss of $(989) thousand in the first nine months of 2009.
Net profit for the third quarter of 2010 was $874 thousand, or $0.10 per diluted share, compared to a net loss of $(575) thousand, or $(0.06) per diluted share recorded in the same quarter of 2009.
In the first nine months of 2010, net profit was $1.36 million, or $0.15 per diluted share, compared to a net loss of $(907) thousand, or $(0.10) per diluted share, in the first nine months of 2009.
Conference Call
Cimatron’s management will host a conference call today, November 10th, 2010 at 9:00 EST, 16:00 Israel time. On the call, management will review and discuss the results, and will answer questions by investors.
To participate, please call one of the following teleconferencing numbers. Please begin placing your call at least 5 minutes before the conference call commences.
USA: +1-888-668-9141
International: +972-3-9180609
Israel: 03-9180609
For those unable to listen to the live call, a replay of the call will be available from the day after the call at the investor relations section of Cimatron’s website, at: http://www.cimatron.com
Reconciliation between results on a GAAP and Non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income included herein. Non-GAAP financial measures consist of GAAP financial measures adjusted to include recognition of deferred revenues of acquired companies and to exclude amortization of acquired intangible assets and deferred income tax, as well as certain business combination accounting entries. The purpose of such adjustments is to give an indication of our performance exclusive of non-cash charges and other items that are considered by management to be outside of our core operating results. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.
Our management regularly uses our supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. We believe that these non-GAAP measures help investors to understand our current and future operating performance, especially as our two most recent acquisitions have resulted in amortization and non-cash items that have had a material impact on our GAAP results. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies.
About Cimatron
With over 25 years of experience and more than 40,000 installations worldwide, Cimatron is a leading provider of integrated, CAD/CAM solutions for mold, tool and die makers, as well as manufacturers of discrete parts. Cimatron is committed to providing comprehensive, cost-effective solutions that streamline manufacturing cycles, enable collaboration with outside vendors, and ultimately shorten product delivery time.
The Cimatron product line includes the CimatronE and GibbsCAM brands with solutions for mold design, die design, electrodes design, 2.5 to 5 axes milling, wire EDM, turn, Mill-turn, rotary milling, multi-task machining, and tombstone machining. Cimatron’s subsidiaries and extensive distribution network serve and support customers in the automotive, aerospace, medical, consumer plastics, electronics, and other industries in over 40 countries worldwide.
Cimatron is publicly traded on the NASDAQ exchange under the symbol CIMT. For more information, please visit the company web site at: http://www.cimatron.com.
Safe Harbor Statement
This press release includes forward looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated. Such statements may relate to the Company’s plans, objectives and expected financial and operating results. The words “may,” “could,” “would,” “will,” “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” and similar expressions or variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. The risks and uncertainties that may affect forward looking statements include, but are not limited to: currency fluctuations, global economic and political conditions, marketing demand for Cimatron products and services, long sales cycle, new product development, assimilating future acquisitions, maintaining relationships with customers and partners, and increased competition. For more details about the risks and uncertainties that relate to the Company’s business, refer to the Company’s filings with the Securities and Exchange Commission. The Company cannot assess the impact of or the extent to which any single factor or risk, or combination of them, may cause. Cimatron undertakes no obligation to publicly update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
CIMATRON LIMITED
CONSOLIDATED STATEMENTS OF INCOME
(US Dollars in thousands, except for per share data)
Three months ended Nine months ended
September 30, September 30,
2010 2009 2010 2009
Total revenue 8,745 7,229 25,061 23,195
Total cost of revenue 1,419 1,420 4,242 4,467
Gross profit 7,326 5,809 20,819 18,728
Research and development
expenses, net 1,493 1,497 4,322 4,389
Selling, general and
administrative expenses 5,354 5,213 15,771 16,069
Operating income (loss) 479 (901) 726 (1,730)
Financial income
(expenses), net 236 (8) 54 (17)
Taxes on income (376) 144 (256) 310
Other 1 (3) (7) -
Net income (loss) 340 (768) 517 (1,437)
Less: Net (income) loss
attributable to the
noncontrolling interest (20) 37 (19) 60
Net income (loss)
attributable to
Cimatron's shareholders $ 320 $ (731) $ 498 $ (1,377)
Net income (loss) per
share - basic and diluted $ 0.04 $ (0.08) $ 0.06 $ (0.15)
Weighted average number
of shares outstanding
Basic EPS
(in thousands) 8,961 9,131 9,014 9,178
Diluted EPS
(in thousands) 8,961 9,131 9,014 9,178
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Three months ended Three months ended
September 30, September 30,
2010 2009
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue 8,745 - 8,745 7,229 - 7,229
Total cost of
revenue(1) 1,419 (147) 1,272 1,420 (147) 1,273
Gross profit 7,326 147 7,473 5,809 147 5,956
Research and
development
expenses, net 1,493 - 1,493 1,497 - 1,497
Selling, general
and administrative
expenses(1) 5,354 (99) 5,255 5,213 (100) 5,113
Operating income
(loss) 479 246 725 (901) 247 (654)
Financial income
(expenses), net 236 - 236 (8) - (8)
Taxes on income(2) (376) 308 (68) 144 (91) 53
Other 1 - 1 (3) - (3)
Net income (loss) 340 554 894 (768) 156 (612)
Less: Net (income)
loss attributable
to the noncontrolling
interest (20) - (20) 37 - 37
Net income (loss)
attributable to
Cimatron's
shareholders $ 320 $ 554 $ 874 $ (731) $ 156 $ (575)
Net income (loss)
per share - basic
and diluted $ 0.04 $ 0.10 $ (0.08) $ (0.06)
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 8,961 8,961 9,131 9,131
Diluted EPS
(in thousands) 8,961 8,961 9,131 9,131
CIMATRON LIMITED
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION
(US Dollars in thousands, except for per share data)
Nine months ended Nine months ended
September 30, September 30,
2010 2009
GAAP Adj. NON-GAAP GAAP Adj. NON-GAAP
Total revenue 25,061 - 25,061 23,195 - 23,195
Total cost of
revenue(1) 4,242 (441) 3,801 4,467 (441) 4,026
Gross profit 20,819 441 21,260 18,728 441 19,169
Research and
development
expenses, net 4,322 - 4,322 4,389 - 4,389
Selling, general
and administrative
expenses(1) 15,771 (297) 15,474 16,069 (300) 15,769
Operating income
(loss) 726 738 1,464 (1,730) 741 (989)
Financial income
(expenses), net 54 - 54 (17) - (17)
Taxes on income(2) (256) 126 (130) 310 (271) 39
Other (7) - (7) - - -
Net income (loss) 517 864 1,381 (1,437) 470 (967)
Less: Net (income)
loss attributable
to the noncontrolling
interest (19) - (19) 60 - 60
Net income (loss)
attributable to
Cimatron's
shareholders $ 498 $ 864 $ 1,362 $ (1,377) $ 470 $ (907)
Net income (loss)
per share - basic
and diluted $ 0.06 $ 0.15 $ (0.15) $ (0.10)
Weighted average
number of shares
outstanding
Basic EPS
(in thousands) 9,014 9,014 9,178 9,178
Diluted EPS
(in thousands) 9,014 9,014 9,178 9,178
CIMATRON LIMITED
CONSOLIDATED BALANCE SHEETS
(US Dollars in thousands)
September 30, December 31,
2010 2009
ASSETS
CURRENT ASSETS:
Total cash, cash equivalents and
short-term investments $ 10,173 $ 6,684
Trade receivables 5,462 5,422
Other current assets 2,752 3,308
Total current assets 18,387 15,414
Deposits with insurance companies
and severance pay fund 3,126 2,935
Net property and equipment 931 1,046
Total other assets 12,800 13,285
Total assets $ 35,244 $ 32,680
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Short-term bank credit $ 114 $ 456
Trade payables 1,984 1,064
Accrued expenses and other liabilities 7,136 6,991
Deferred revenues 4,492 2,397
Total current liabilities 13,726 10,908
LONG-TERM LIABILITIES:
Accrued severance pay 4,136 4,104
Long-term loan 147 204
Deferred tax liability 1,093 1,365
Total long-term liabilities 5,376 5,673
Total shareholders' equity 16,142 16,099
Total liabilities and shareholders'
equity $ 35,244 $ 32,680
CIMATRON LIMITED
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(US Dollars in thousands)
Accumulated
Additional other
Noncontrolling Share paid-in comprehensive
Interest capital capital income (loss)
Balance at
December 31, 2009 $ (48) $ 304 $ 18,204 $ 75
Changes during the
nine months ended
September 30, 2010:
Net income (loss) 19
Exercise of share
options - 11
Unrealized loss on
derivative instruments (116)
Other 281
Stock option compensation 45
Investment in treasury
stock
Foreign currency
translation adjustment (485)
Total comprehensive
income
Balance at September 30,
2010 $ (29) $ 304 $ 18,260 $ (245)
Table cont'd.
CIMATRON LIMITED
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(US Dollars in thousands)
Retained
earnings Total
(accumulated Treasury Comprehensive shareholders'
deficit) stock income (loss) equity
Balance at
December 31, 2009 $ (1,894) $ (542) $ 16,099
Changes during the
nine months ended
September 30, 2010:
Net income (loss) 498 517 517
Exercise of share
options 11
Unrealized loss on
derivative instruments (116) (116)
Other 281 281
Stock option
compensation 45
Investment in
treasury stock (210) (210)
Foreign currency
translation adjustment (485) (485)
Total comprehensive 197
income
Balance at
September 30, 2010 $ (1,396) $ (752) $ 16,142
CIMATRON LIMITED
STATEMENTS OF CASH FLOWS
(US Dollars in thousands)
Nine months ended
September 30,
2010 2009
Cash flows from operating activities:
Net income (loss) $ 517 $(1,437)
Adjustments to reconcile net loss
to net cash provided by operating activities:
Depreciation and amortization 1,131 1,224
Increase (decrease) in accrued severance pay (7) 301
Gain from sale of property and equipment, net 5 -
Stock option compensation 45 54
Deferred taxes, net 176 (259)
Changes in assets and liabilities:
Decrease in accounts receivable and
prepaid expenses 114 2,245
Decrease (increase) in inventory 3 (20)
Increase in deposits with insurance
companies and severance pay fund (191) (241)
Increase in trade payables, accrued expenses and
other liabilities 2,540 457
Net cash provided by operating activities 4,333 2,324
Cash flows from investing activities:
Purchase of property and equipment (271) (264)
Net cash used in investing activities (271) (264)
Cash flows from financing activities:
Short-term bank credit (367) (33)
Long-term bank credit (66) (4)
Proceeds from issuance of shares upon
exercise of options 11 -
Investment in treasury stock (210) (128)
Net cash used in financing activities (632) (165)
Net increase in cash and cash equivalents 3,430 1,895
Effect of exchange rate changes on cash 59 (108)
Cash and cash equivalents at beginning of period 6,684 5,727
Cash and cash equivalents at end of period $ 10,173 $ 7,514
Appendix A - Non-cash transactions
Purchase of property on credit $ 28 $ 20
Contact:
Ilan Erez, Chief Financial Officer
Cimatron Ltd.
Tel.: +972-73-2370237
E-mail: ilane@cimatron.com
TraderPower Featured Companies
- Astrotech Corp. (NASDAQ: ASTC)
- Cepton Inc. (NASDAQ: CPTN)
- Clene Inc. (NASDAQ: CLNN)
- CNS Pharmaceuticals Inc. (NASDAQ: CNSP)
- Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)
- Freight Technologies Inc. (NASDAQ: FRGT)
- InMed Pharmaceuticals Inc. (NASDAQ: INM)
- Lexaria Bioscience Corp. (NASDAQ: LEXX)
- Mullen Automotive Inc. (NASDAQ: MULN)
- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
Top Small Cap Market News
- $FNGR InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Agreements to Add Charging Terminal Access for Users of Growing Da Ge App
- $FRGT InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Appointed as Solave’s Logistics Solutions Provider for Cross-Border Operations
- $PXMD InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
- $RFLXF Malaysian Company to Transform Agricultural Waste into Graphite in Nevada
- $FNICF Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects
- $CIPI Green-Energy Projects Face Financing Woes Amid High Interest Rates
- $LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida
- $APAAF InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project
Recent Posts
- $APAAF InvestorNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Files NI 43-101 Technical Report for Goiás-Based PCH Ionic Adsorption Clay Project
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with Four-Facility Behavioral Health Provider in Florida
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Exercise Warrants for ~$6.2M
- $LGVN New Study Shows Social Isolation, Frailty Worsen Health Risks for Aging People
- $CIPI Green-Energy Projects Face Financing Woes Amid High Interest Rates
- $FNICF Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Sees Great Potential Across its Saskatchewan Nickel Projects
- $RFLXF Malaysian Company to Transform Agricultural Waste into Graphite in Nevada
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
Recent Comments
Archives
- April 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009